DRAK2 antibody (AA 310-359)
-
- Target See all DRAK2 (STK17B) Antibodies
- DRAK2 (STK17B) (serine/threonine Kinase 17b (STK17B))
-
Binding Specificity
- AA 310-359
-
Reactivity
- Human
-
Host
- Rabbit
-
Clonality
- Polyclonal
-
Conjugate
- This DRAK2 antibody is un-conjugated
-
Application
- Western Blotting (WB)
- Specificity
- Human STK17B / DRAK2
- Purification
- Affinity purified
- Immunogen
-
Synthetic peptide located between aa310-359 of human STK17B (Q53QE7, NP_004217). Percent identity by BLAST analysis: Human (100%).
Type of Immunogen: Synthetic peptide - Top Product
- Discover our top product STK17B Primary Antibody
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Comment
-
Target Species of Antibody: Human
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Distilled water
- Concentration
- Lot specific
- Buffer
- Lyophilized from PBS, 2 % sucrose.
- Storage
- 4 °C,-20 °C
- Storage Comment
-
Short term: 4°C
Long term: -20°C.
-
- Target
- DRAK2 (STK17B) (serine/threonine Kinase 17b (STK17B))
- Alternative Name
- STK17B / DRAK2 (STK17B Products)
- Synonyms
- zgc:65989 antibody, STK17B antibody, DRAK2 antibody, Drak2 antibody, 3110009A03Rik antibody, AI120141 antibody, serine/threonine kinase 17b (apoptosis-inducing) antibody, serine/threonine kinase 17b antibody, stk17b antibody, STK17B antibody, Stk17b antibody
- Background
-
Name/Gene ID: STK17B
Subfamily: DAPK
Family: Protein Kinase
Synonyms: STK17B, DRAK2, Serine/threonine kinase 17b - Gene ID
- 9262
- NCBI Accession
- NP_004217
-